| Detected | Trial | Change |
|---|---|---|
| 2026-07-19 | NCT07180862 A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants |
Enrollment increased: 140 -> 160 participants |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07515079 | Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema | Diabetic Macular Edema (DME) | Recruiting |
| Phase 2/3 | |||
| NCT06123884 | BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1)… | Cervical Cancer | Recruiting |
| NCT07499700 | A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal… | Minimal Change Disease (MCD) | Recruiting |
| Phase 2 | |||
| NCT06044350 | A Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum… | Optic Neuromyelitis Spectrum Disease | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT06376136 | A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and… | Advanced Solid Tumors | Recruiting |
| NCT06341114 | A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics… | Advanced Solid Tumors | Active, Not Recruiting |
| NCT06094179 | Evaluate the Safety, Tolerability of BAT6026 | Dermatitis, Atopic | Active, Not Recruiting |
| Phase 1 | |||
| NCT05620017 | Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for… | Advanced Solid Tumors | Recruiting |
| NCT07180862 | A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants | Carcinoma, Non-Small-Cell Lung | Recruiting |